NASDAQ:GHSI • US40145Q5009
The current stock price of GHSI is 3.25 USD. In the past month the price decreased by -67.2%. In the past year, price decreased by -53.64%.
ChartMill assigns a fundamental rating of 5 / 10 to GHSI. No worries on liquidiy or solvency for GHSI as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months GHSI reported a non-GAAP Earnings per Share(EPS) of 0.43. The EPS increased by 154.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 99.1% | ||
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| Debt/Equity | 0 |
7 analysts have analysed GHSI and the average price target is 40.8 USD. This implies a price increase of 1155.38% is expected in the next year compared to the current price of 3.25.
For the next year, analysts expect an EPS growth of -669.3% and a revenue growth 9.56% for GHSI
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 35.13 | 39.154B | ||
| KVUE | KENVUE INC | 16.59 | 35.829B | ||
| ELF | ELF BEAUTY INC | 22.82 | 4.813B | ||
| IPAR | INTERPARFUMS INC | 20.29 | 3.278B | ||
| COTY | COTY INC-CL A | 5.06 | 2.209B | ||
| BRBR | BELLRING BRANDS INC | 7.92 | 2.096B | ||
| OLPX | OLAPLEX HOLDINGS INC | 15.79 | 1.041B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 8.66 | 1.023B | ||
| NATR | NATURES SUNSHINE PRODS INC | 26.38 | 470.925M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 5.83 | 407.55M |
View all stocks in the Personal Care Products Industry | View all stocks in the Consumer Staples Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Guardion Health Sciences, Inc. engages in the business of developing and distributing clinically supported nutrition, medical foods, and dietary supplements. The company is headquartered in Houston, Texas and currently employs 9 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The firm sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. The company sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.
GUARDION HEALTH SCIENCES INC
2925 Richmond Avenue, Suite 1200
Houston TEXAS 92128 US
CEO: Bret Scholtes
Employees: 9
Phone: 18008735141
Guardion Health Sciences, Inc. engages in the business of developing and distributing clinically supported nutrition, medical foods, and dietary supplements. The company is headquartered in Houston, Texas and currently employs 9 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The firm sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. The company sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.
The current stock price of GHSI is 3.25 USD. The price decreased by -0.31% in the last trading session.
GUARDION HEALTH SCIENCES INC (GHSI) has a dividend yield of 153.85%. The yearly dividend amount is currently 0.
GHSI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The next ex-dividend date for GUARDION HEALTH SCIENCES INC (GHSI) is September 24, 2024.
The Revenue of GUARDION HEALTH SCIENCES INC (GHSI) is expected to grow by 9.56% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
You can find the ownership structure of GUARDION HEALTH SCIENCES INC (GHSI) on the Ownership tab.